297 related articles for article (PubMed ID: 27841789)
21. The cystic fibrosis airway microbiome.
Rabin HR; Surette MG
Curr Opin Pulm Med; 2012 Nov; 18(6):622-7. PubMed ID: 22965275
[TBL] [Abstract][Full Text] [Related]
22. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy.
Levy J
Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160
[TBL] [Abstract][Full Text] [Related]
23. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
[TBL] [Abstract][Full Text] [Related]
24. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation.
Bonvillain RW; Valentine VG; Lombard G; LaPlace S; Dhillon G; Wang G
J Heart Lung Transplant; 2007 Sep; 26(9):890-7. PubMed ID: 17845927
[TBL] [Abstract][Full Text] [Related]
25. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
[TBL] [Abstract][Full Text] [Related]
26. The airway microbiota in early cystic fibrosis lung disease.
Frayman KB; Armstrong DS; Grimwood K; Ranganathan SC
Pediatr Pulmonol; 2017 Nov; 52(11):1384-1404. PubMed ID: 28815937
[TBL] [Abstract][Full Text] [Related]
27. Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway.
Fick RB; Sonoda F; Hornick DB
Semin Respir Infect; 1992 Sep; 7(3):168-78. PubMed ID: 1475541
[TBL] [Abstract][Full Text] [Related]
28. Associations between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic Fibrosis.
Hoen AG; Li J; Moulton LA; O'Toole GA; Housman ML; Koestler DC; Guill MF; Moore JH; Hibberd PL; Morrison HG; Sogin ML; Karagas MR; Madan JC
J Pediatr; 2015 Jul; 167(1):138-47.e1-3. PubMed ID: 25818499
[TBL] [Abstract][Full Text] [Related]
29. Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease.
Cribbs SK; Beck JM
Transl Res; 2017 Jan; 179():84-96. PubMed ID: 27559681
[TBL] [Abstract][Full Text] [Related]
30. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
[TBL] [Abstract][Full Text] [Related]
31. [The lung microbiome in 2015: a window on chronic lung diseases].
Andréjak C; Delhaes L
Med Sci (Paris); 2015 Nov; 31(11):971-8. PubMed ID: 26576604
[TBL] [Abstract][Full Text] [Related]
32. Host-pathogen interplay in the respiratory environment of cystic fibrosis.
Yonker LM; Cigana C; Hurley BP; Bragonzi A
J Cyst Fibros; 2015 Jul; 14(4):431-439. PubMed ID: 25800687
[TBL] [Abstract][Full Text] [Related]
33. The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis.
Amin R; Lam M; Dupuis A; Ratjen F
Pediatr Pulmonol; 2011 Jun; 46(6):554-8. PubMed ID: 21337727
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis.
Sherrard LJ; Tunney MM; Elborn JS
Lancet; 2014 Aug; 384(9944):703-13. PubMed ID: 25152272
[TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
[TBL] [Abstract][Full Text] [Related]
36. Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis.
Langan KM; Kotsimbos T; Peleg AY
Curr Opin Infect Dis; 2015 Dec; 28(6):547-56. PubMed ID: 26524327
[TBL] [Abstract][Full Text] [Related]
37. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
[TBL] [Abstract][Full Text] [Related]
38. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
[TBL] [Abstract][Full Text] [Related]
39. Is the type of chronic pulmonary infection a determinant of lung function outcomes in adult patients with cystic fibrosis?
Lopes AJ; Mafort TT; de Sá Ferreira A; Santos de Castro MC; Cássia de Firmida M; de Andrade Marques E
Monaldi Arch Chest Dis; 2012; 77(3-4):122-8. PubMed ID: 23461248
[TBL] [Abstract][Full Text] [Related]
40. Anaerobes in cystic fibrosis patients' airways.
Lamoureux C; Guilloux CA; Beauruelle C; Jolivet-Gougeon A; Héry-Arnaud G
Crit Rev Microbiol; 2019 Feb; 45(1):103-117. PubMed ID: 30663924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
